Inden for hver frekvensgruppering præsenteres bivirkninger observeret under behandlingen eller inden for 30 dage efter gennemført behandling med MabCampath efter faldende grad.
Within each frequency grouping, undesirable effects observed during treatment or within 30 days following the completion of treatment with MabCampath, are presented in order of decreasing seriousness.